The Nov 2017 update/preso 'flagged' the 'Pivotal Trial/Study' pathway for the MITCI trial for the first time then, which is why I suspected (and still do), that BMS obviously had/have done enough 'homework' (at that stage) on the 'logistics' of realising that outcome to flag it as such, they'd only be in a better position now, with more data, considering this data has a 10/03/18 cutoff...
Play it by ear I guess...
ML
VLA Price at posting:
$1.69 Sentiment: Hold Disclosure: Held
